DL-Theanine

DL-Theanine is a DL mixture of the non-proteinogenic amino acid theanine, structurally characterized by a γ-glutamyl backbone linked to an ethylamide-bearing side chain, with both enantiomeric forms present at the chiral center. The molecule contains a free carboxylic acid and an amide functional group, enabling predictable acid-base behavior and participation in coupling chemistry after appropriate activation. The ethylamide side chain contributes to hydrogen-bonding and polarity modulation, while the DL stereochemical composition makes it suitable for method development, analytical studies, and downstream derivatization where racemic material is acceptable. Theanine's amino acid framework also supports conversion into protected derivatives and peptide-compatible building blocks for synthetic and biochemical research workflows.

1. Peptide Synthesis

DL-Theanine is applied in peptide synthesis workflows where a γ-glutamyl-like amino acid scaffold and an amide-bearing side chain can be incorporated into dipeptides and longer peptide analogs. The presence of a carboxylic acid and an amino functionality allows formation of peptide bonds via standard coupling strategies after conversion to an activated acid or a protected amino acid derivative. Racemic stereochemistry can be leveraged for generating libraries of peptide-like constructs for structure-activity relationship studies or for preparing reference materials when enantiopure access is not required. Downstream, the resulting theanine-containing peptides can serve as substrates for peptidase screening, as internal standards in peptide LC-MS methods, or as intermediates toward peptidomimetic scaffolds.

2. Chiral Derivatization Studies

DL-Theanine is used in analytical research and chiral method development because its DL composition provides a controlled starting point for stereochemical differentiation. The amino acid functionality and carboxyl group enable derivatization to diastereomeric derivatives using chiral reagents, facilitating separation by chromatography or improved detection in mass spectrometry. The ethylamide side chain contributes stable amide signals that can improve analytical robustness for amino acid profiling and impurity characterization. Generated derivatives can be employed as analytical standards for amino acid derivatization validation, racemate-to-enantiomer conversion monitoring, and method transfer across laboratories.

3. Chemical Biology Probes

DL-Theanine is suitable for chemical biology research where an amino acid-like scaffold with an amide-containing side chain can be used to probe receptor-binding motifs or transporter-associated recognition in vitro. The carboxyl group and amide functionality enable conjugation handles after functional group activation, including formation of amide-linked probes and attachment to biopolymers or affinity tags. Racemic material can support initial screening of binding and uptake behavior, while later stages may require enantiopure follow-up depending on stereochemical selectivity. Downstream probe generation can support molecular recognition studies, competitive binding assays, and the construction of labeled analogs for biochemical investigation.

4. Bioconjugation Intermediates

DL-Theanine is applied as an amino acid-based intermediate for bioconjugation strategies that require a stable amide linkage and amino acid-derived polarity. The γ-glutamyl-like backbone can be transformed into protected derivatives, enabling controlled coupling to activated esters or activated carboxylic acids on biomolecule surfaces. The ethylamide side chain can remain intact during conjugation, providing a consistent functional environment for downstream labeling, immobilization, or surface modification. Resulting conjugates can be utilized in affinity capture workflows, biomolecule immobilization for analytical assays, and preparation of peptide-protein conjugates that rely on amino acid chemistry for stable linkage formation.

5. Pharmaceutical Intermediate Preparation

DL-Theanine is used in pharmaceutical intermediate preparation and process chemistry development where amino acid functionality supports scalable conversion into protected amino acid derivatives and coupling-ready intermediates. The carboxylic acid can be activated or esterified, while the amide-bearing side chain can be preserved or selectively modified depending on the target synthetic route. Racemic starting material is often compatible with process development stages that focus on route robustness, impurity profiling, and intermediate qualification prior to any stereochemical refinement. Downstream, theanine-derived intermediates can feed into synthesis of peptidomimetics, amide-rich scaffolds, and amino acid analogs used as research compounds in medicinal chemistry programs.

6. Fine Chemical Synthesis

DL-Theanine is suitable for fine chemical synthesis and specialty chemical production where amino acid-derived scaffolds enable construction of amide-containing heteroatom-rich molecules. The combination of carboxylic acid and amide functionalities supports sequential transformations such as protection/deprotection planning, activation for carbon-nitrogen bond formation, and controlled derivatization for downstream scaffold assembly. The stereochemical mixture can be advantageous for generating racemic libraries of analogs during lead exploration or for producing reference materials for impurity and stability studies. Generated derivatives can serve as intermediates for amino acid ester synthesis, peptidomimetic construction, and manufacturing-oriented preparation of standardized chemical building blocks.

1. Odorant binding protein based biomimetic sensors for detection of alcohols associated with Salmonella contamination in packaged beef

2. Oleic acid and glucose regulate glucagon-like peptide 1 receptor expression in a rat pancreatic ductal cell line

3. C-peptide and its C-terminal fragments improve erythrocyte deformability in type 1 diabetes patients

4. Immune responses to peptides containing homocitrulline or citrulline in the DR4-transgenic mouse model of rheumatoid arthritis

5. The effect of B-type allatostatin neuropeptides on crosstalk between the insect immune response and cold tolerance